The SEC Is Asking About Our Segments and Our CODM. How Do We Respond Without Making It Worse?

A segment comment letter reads politely and lands hard. The first comment usually looks like some version of: "Please identify your CODM, describe the information regularly provided to the CODM and how frequently it is reviewed, and tell us how you determined you have one reportable segment." Then the follow-up: "Please provide us the reporting package provided to the CODM and the materials provided to your board." That second request is the whole ballgame, the staff is not asking for your reasoning, they are asking for your evidence, and they will read it against your earnings calls, your investor deck, and your website.

Here is how to run the response so a two-round comment exchange does not become a restatement of your segment footnote.

Why did we get this comment?

Segment comments are rarely random. The staff screens for observable inconsistencies between the 10-K and everything else you publish:

• The earnings call discusses "our three businesses" with separate revenue and margin color; the 10-K reports one segment.
• The investor deck shows product-line P&L detail the footnote says the CODM doesn't manage on.
• MD&A explains consolidated results by referencing divisional performance, evidence discrete information exists.
• An acquisition added a business with obviously different economics, and the segment footnote didn't change.
• Post-ASU 2023-07: the significant-expense disclosure implies a CODM package richer than the single-segment conclusion suggests.

Before drafting a word, run your own inconsistency screen across the same documents the staff read, the free ASC 280 segment reporting tool includes this cross-document screen as the first step of its assessment. The response has to account for every inconsistency, because the staff already has.

What will the staff actually ask us to produce?

Expect requests for: the CODM reporting package for several recent quarters; board and executive committee materials; your organizational chart; budgets and forecasts and the level at which they are prepared and reviewed; and how executive compensation, especially the CODM's direct reports, is determined. The compensation question is underrated: if division presidents are bonused on division P&L, the staff infers those P&Ls are reviewed for performance assessment, which is half the operating-segment definition in ASC 280-10-50-1.

Do not curate the production. Producing a sanitized subset that later proves incomplete converts a disclosure disagreement into a credibility problem, and credibility is the only asset you have in round two.

How do we defend a single-segment or aggregated position?

With the standard's own structure, mapped to your facts:

1. CODM identification (ASC 280-10-50-5): who allocates resources and assesses performance, evidenced by what they receive and what decisions they make, not by title.
2. Operating segment analysis (ASC 280-10-50-1): address the discrete-information criterion head-on. The existence of product-line data somewhere in the company does not create an operating segment; the question is whether the CODM regularly reviews it to allocate resources. If detail appears in the CODM package, explain its role honestly, context versus management basis, and expect skepticism.
3. Aggregation (ASC 280-10-50-11), if that's your position: demonstrate similar economic characteristics quantitatively, multi-year gross margin trends by operating segment, plus all five qualitative criteria. If margins have diverged, address the divergence directly with the reasons and the expected long-term convergence. A response that quotes the five criteria without numbers invites the follow-up letter.
4. Thresholds and the 75% test (ASC 280-10-50-12 and 50-14): show the math.

This is exactly the file you should have built before the letter arrived. The free ASC 280 segment reporting tool assembles it: CODM evidence inventory, aggregation support matrix, threshold calculations, as a standing memo, so the comment response is an extraction exercise rather than a six-week reconstruction.

What outcomes should we plan for?

Three, in ascending order of pain: the staff accepts your analysis (often with a request to enhance disclosure prospectively); you agree to disaggregate in future filings, the common negotiated landing, disclosed prospectively with recast comparatives under ASC 280-10-50-34; or, rarely, the position is untenable enough to require amendment. The negotiated landing is why tone matters: a response that engages the facts candidly gets prospective treatment; a response that stonewalls invites escalation. The SEC's 1998 enforcement action against Sony, a $1 million penalty tied to burying Sony Pictures' losses inside an aggregated "entertainment" segment, remains the standing reminder that segment presentation can graduate from comment letter to enforcement when the aggregation conceals known deterioration.

One more discipline: whatever you tell the staff becomes a representation your future filings must live up to. If you tell them the CODM package will change, change it. The staff re-reads.

FAQ

How long do we have to respond to an SEC comment letter?

The letter typically requests a response within ten business days. Extensions are routinely granted for segment comments, ask early, because assembling CODM packages and board materials responsibly takes longer than ten days.

Will the SEC make us restate prior segment disclosures?

Usually not. The typical negotiated outcome on segment disaggregation is prospective presentation with prior periods recast for comparability (ASC 280-10-50-34), not an amended filing, unless the prior presentation was materially misleading.

Is the comment letter public?

Yes, eventually. Comment letters and responses are released on EDGAR no earlier than 20 business days after the review concludes. Draft every response knowing your investors, competitors, and plaintiffs' bar will read it.

Can we refuse to provide the CODM package?

You can seek confidential treatment for supplemental materials under Rule 83, and companies routinely provide the package supplementally with a confidential-treatment request and ask for its return. Refusing outright stalls the review and signals the package contradicts the footnote.